DNA Link Statistics

Total Valuation

DNA Link has a market cap or net worth of KRW 160.22 billion. The enterprise value is 174.62 billion.

Market Cap	160.22B
Enterprise Value	174.62B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

DNA Link has 22.95 million shares outstanding. The number of shares has increased by 15.03% in one year.

Current Share Class	n/a
Shares Outstanding	22.95M
Shares Change (YoY)	+15.03%
Shares Change (QoQ)	+13.92%
Owned by Insiders (%)	4.39%
Owned by Institutions (%)	n/a
Float	17.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.74
PB Ratio	6.29
P/TBV Ratio	6.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-16.17
EV / Sales	10.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.43

Financial Position

The company has a current ratio of 0.53, with a Debt / Equity ratio of 0.76.

Current Ratio	0.53
Quick Ratio	0.31
Debt / Equity	0.76
Debt / EBITDA	n/a
Debt / FCF	-0.81
Interest Coverage	-15.99

Financial Efficiency

Return on equity (ROE) is -42.11% and return on invested capital (ROIC) is -15.21%.

Return on Equity (ROE)	-42.11%
Return on Assets (ROA)	-12.21%
Return on Invested Capital (ROIC)	-15.21%
Return on Capital Employed (ROCE)	-33.40%
Revenue Per Employee	196.39M
Profits Per Employee	-133.35M
Employee Count	81
Asset Turnover	0.34
Inventory Turnover	4.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +161.02% in the last 52 weeks. The beta is 0.03, so DNA Link's price volatility has been lower than the market average.

Beta (5Y)	0.03
52-Week Price Change	+161.02%
50-Day Moving Average	6,029.60
200-Day Moving Average	4,169.30
Relative Strength Index (RSI)	58.74
Average Volume (20 Days)	255,276

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DNA Link had revenue of KRW 15.91 billion and -10.80 billion in losses. Loss per share was -542.00.

Revenue	15.91B
Gross Profit	2.71B
Operating Income	-9.10B
Pretax Income	-10.80B
Net Income	-10.80B
EBITDA	-7.47B
EBIT	-9.10B
Loss Per Share	-542.00

Full Income Statement

Balance Sheet

The company has 4.75 billion in cash and 19.14 billion in debt, giving a net cash position of -14.39 billion or -626.99 per share.

Cash & Cash Equivalents	4.75B
Total Debt	19.14B
Net Cash	-14.39B
Net Cash Per Share	-626.99
Equity (Book Value)	25.03B
Book Value Per Share	1,110.18
Working Capital	-12.87B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.78 billion and capital expenditures -16.72 billion, giving a free cash flow of -23.50 billion.

Operating Cash Flow	-6.78B
Capital Expenditures	-16.72B
Free Cash Flow	-23.50B
FCF Per Share	-1,023.63

Full Cash Flow Statement

Margins

Gross margin is 17.05%, with operating and profit margins of -57.20% and -67.90%.

Gross Margin	17.05%
Operating Margin	-57.20%
Pretax Margin	-67.90%
Profit Margin	-67.90%
EBITDA Margin	-46.94%
EBIT Margin	-57.20%
FCF Margin	n/a

Dividends & Yields

DNA Link does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.03%
Shareholder Yield	-15.03%
Earnings Yield	-6.74%
FCF Yield	-14.67%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DNA Link has an Altman Z-Score of -1.44. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.44
Piotroski F-Score	n/a